Tag Archives: CE

For sell Brand New Apple iPhone 5S 64GB -$350,Nokia Lumia 80

By ramadans

SERCOM LIMITED® we are one of the leading mobile phone distributorsis. We are legitimate registered company under government registration and licensed,

Registered No.05031576

SERCOM LIMITED® is an Approved dealer, specialized in the distributors of Mobile phones, Laptops, Games, Mobile accessories, computer etc. Our objective is

to develop long-term relationships with our customers. To do so we continuously provide our existing customers new products advanced designs and patented

innovations so that they can stay on the top of their markets. Mind you all the product below are brand new and they come with the minimum of 1 full

international warranty.

We supply superior quality products all products strictly follow the standards of CE, FCC and RoHS, and are carefully inspected by a responsible QA team

before packaging.

We shipout worldwide through Professional and reliable courier company e.g FEDEX EXPRESS ,DHL and UPS within 24hrs of contract sealed, Customers never

experience what is called Breach of contract since our operation, Fidelity guarantee our service, our product are 100% international warranty and guarantee.

1. Complete accessories (Well packed and sealed in original company box)

2. Unlocked / SIM FREE.

3. Brand new (original manufacturer) box – no copies

4. All phones have English language as default

5. All material (software, manual) – car chargers – home chargers – USB data cables -holsters/belt clips – wireless headsets(Bluetooth) -leather and non-

leather carrying cases – batteries.

PAYMENT METHOD: PAYPAL, BANK TRANSFER, WESTERN UNION, MONEY GRAM, LIBERTY RESERVE

Company information and contact details:

Company Name: SERCOM LIMITED®

Registered No.05031576

Sales Manager: KRZYSZTOF KUCHARSKI

Company Address:381 Ashford Road, Laleham, Staines, Middlesex, Tw18 1qg

CONTACT EMAILS & SALES INQUIRY: sales.sercomlimited@gmail.com, sercomlimited@msn.com, sercom4u@yahoo.com

WEBSITE: SerCom

BEST OFFER:

BUY 2 UNITS GET 1 FOR FREE.

BUY 4 UNITS GET 2 UNITS FOR FREE WITH FREE SHIPPING.

BUY 10 UNITS GET 5 UNITS FOR FREE WITH FREE SHIPPING.
PRICELIST: BEST OFFER:
BUY 2 UNITS GET 1 FOR FREE.
BUY 4 UNITS GET 2 UNITS FOR FREE WITH FREE SHIPPING.
BUY 10 UNITS GET 5 UNITS FOR FREE WITH FREE SHIPPING.

PRICELIST:

Apple iPads:
Apple iPad 4 Wi-Fi……………………………..$320.00
Apple iPad mini Wi-Fi…………………………$300.00
Apple iPad 3 Wi-Fi + 4G 64GB……………..$280.00
Apple iPad 3 Wi-Fi + 4G 32GB……………..$280.00
Apple iPad 3 Wi-Fi + 4G 16GB……………..$300.00
Apple iPad 2 Wi-Fi + 3G 64GB ……… $300.00
Apple iPad 2 Wi-Fi + 3G 32GB ……… $290.00
Apple iPad 2 Wi-Fi + 3G 16GB ……… $270.00
Apple Tablet iPad 64GB (Wi-Fi + 3G) ….. $ 240.00
Apple Tablet iPad 32GB (Wi-Fi + 3G) ….. $ 220.00
Apple Tablet iPad 16GB (Wi-Fi + 3G)….. $ 200.00

Apple iPhone:
Apple iPhone 5 64GB —– $350.00
Apple iPhone 5 32GB —– $350.00
Apple iPhone 5 16GB —— $350.00
Apple iPhone 4S 64GB ——- $320.00
Apple iPhone 4S 32GB —— $ 300.00
Apple iPhone 4S 16GB —– …read more

Source: DoItYourself.com

WTS New Samsung Galaxy S III-$300,Nokia 808 PureView-$320

By ramadans

SERCOM LIMITED® we are one of the leading mobile phone distributorsis. We are legitimate registered company under government registration and licensed,

Registered No.05031576

SERCOM LIMITED® is an Approved dealer, specialized in the distributors of Mobile phones, Laptops, Games, Mobile accessories, computer etc. Our objective is

to develop long-term relationships with our customers. To do so we continuously provide our existing customers new products advanced designs and patented

innovations so that they can stay on the top of their markets. Mind you all the product below are brand new and they come with the minimum of 1 full

international warranty.

We supply superior quality products all products strictly follow the standards of CE, FCC and RoHS, and are carefully inspected by a responsible QA team

before packaging.

We shipout worldwide through Professional and reliable courier company e.g FEDEX EXPRESS ,DHL and UPS within 24hrs of contract sealed, Customers never

experience what is called Breach of contract since our operation, Fidelity guarantee our service, our product are 100% international warranty and guarantee.

1. Complete accessories (Well packed and sealed in original company box)

2. Unlocked / SIM FREE.

3. Brand new (original manufacturer) box – no copies

4. All phones have English language as default

5. All material (software, manual) – car chargers – home chargers – USB data cables -holsters/belt clips – wireless headsets(Bluetooth) -leather and non-

leather carrying cases – batteries.

PAYMENT METHOD: PAYPAL, BANK TRANSFER, WESTERN UNION, MONEY GRAM, LIBERTY RESERVE

Company information and contact details:

Company Name: SERCOM LIMITED®

Registered No.05031576

Sales Manager: KRZYSZTOF KUCHARSKI

Company Address:381 Ashford Road, Laleham, Staines, Middlesex, Tw18 1qg

CONTACT EMAILS & SALES INQUIRY: sales.sercomlimited@gmail.com, sercomlimited@msn.com, sercom4u@yahoo.com

WEBSITE: SerCom

BEST OFFER:

BUY 2 UNITS GET 1 FOR FREE.

BUY 4 UNITS GET 2 UNITS FOR FREE WITH FREE SHIPPING.

BUY 10 UNITS GET 5 UNITS FOR FREE WITH FREE SHIPPING.
PRICELIST: BEST OFFER:
BUY 2 UNITS GET 1 FOR FREE.
BUY 4 UNITS GET 2 UNITS FOR FREE WITH FREE SHIPPING.
BUY 10 UNITS GET 5 UNITS FOR FREE WITH FREE SHIPPING.

PRICELIST:

Apple iPads:
Apple iPad 4 Wi-Fi……………………………..$320.00
Apple iPad mini Wi-Fi…………………………$300.00
Apple iPad 3 Wi-Fi + 4G 64GB……………..$280.00
Apple iPad 3 Wi-Fi + 4G 32GB……………..$280.00
Apple iPad 3 Wi-Fi + 4G 16GB……………..$300.00
Apple iPad 2 Wi-Fi + 3G 64GB ……… $300.00
Apple iPad 2 Wi-Fi + 3G 32GB ……… $290.00
Apple iPad 2 Wi-Fi + 3G 16GB ……… $270.00
Apple Tablet iPad 64GB (Wi-Fi + 3G) ….. $ 240.00
Apple Tablet iPad 32GB (Wi-Fi + 3G) ….. $ 220.00
Apple Tablet iPad 16GB (Wi-Fi + 3G)….. $ 200.00

Apple iPhone:
Apple iPhone 5 64GB —– $350.00
Apple iPhone 5 32GB —– $350.00
Apple iPhone 5 16GB —— $350.00
Apple iPhone 4S 64GB ——- $320.00
Apple iPhone 4S 32GB —— $ 300.00
Apple iPhone 4S 16GB —– …read more

Source: DoItYourself.com

Guided Therapeutics Ships Initial Edition 3 CE Marked LuViva® Advanced Cervical Scan

By Business Wirevia The Motley Fool

Filed under:

Guided Therapeutics Ships Initial Edition 3 CE Marked LuViva ® Advanced Cervical Scan

NORCROSS, Ga.–(BUSINESS WIRE)– Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it shipped its first Edition 3 CE marked LuViva® Advanced Cervical Scan unit to its distributor in Turkey. The delivery is the first of 15 to 20 units expected to be shipped to distributors in the second quarter.

“This shipment represents a significant achievement for the company and, along with the recent units delivered to our Canadian partners, marks the beginning of commercial CE Marked sales of LuViva,” said Mark L. Faupel, Ph.D., CEO and president of Guided Therapeutics, Inc. “We plan to follow up this shipment with additional sales to Europe and Africa later this quarter.”

The LuViva Advanced Cervical Scan is now compliant with both Edition 2 and Edition 3 CE standards, has marketing approval from Health Canada and the Singapore Health Sciences Authority, and is under U.S. Food and Drug Administration Premarket review.

About LuViva ® Advanced Cervical Scan

LuViva is a technologically advanced diagnostic device that scans the cervix with light and uses spectroscopy to measure how light interacts with the cervical tissue. Spectroscopy identifies chemical and structural indicators of precancer that may be below the surface of the cervix or misdiagnosed as benign. This technique is called biophotonics. Unlike Pap, HPV tests or biopsies, LuViva does not require laboratory analysis or a tissue sample, and is designed to provide results immediately, which eliminates costly, painful and unnecessary testing. LuViva is designed for use with women who have undergone initial screening and are called back for follow up with a colposcopy examination, which in many cases, involves taking a biopsy of the cervix. The device is used in conjunction with the LuViva® Cervical Guide single-use patient interface and calibration disposable.

About Guided Therapeutics

Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) is developing a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level. The Company’s first planned product is the LuViva®Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial, with women at risk for cervical disease, the technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. Guided Therapeutics

From: http://www.dailyfinance.com/2013/04/17/guided-therapeutics-ships-initial-edition-3-ce-mar/

SpectraScience and PENTAX Medical Announce Expanded Distribution of WavSTAT4 Optical Biopsy System i

By Business Wirevia The Motley Fool

Filed under:

SpectraScience and PENTAX Medical Announce Expanded Distribution of WavSTAT4 Optical Biopsy System in Europe

SAN DIEGO–(BUSINESS WIRE)– SpectraScience, Inc. (OTCQB:SCIE), a San Diego-based medical device company and PENTAX Europe GmbH (PENTAX Medical herein after) jointly announce that they have agreed on expanded distribution of the WavSTAT4 Optical Biopsy System in Europe. Increased deployments of the WavSTAT4 system is expected in the PENTAX Medical fiscal year (April 2013 – March 2014).

SpectraScience and PENTAX Medical Expand Distribution of WavSTAT4 Optical Biopsy System in Europe (Photo: Business Wire)

As previously announced in June 2012, SpectraScience entered into an exclusive five-year agreement with PENTAX Medical to distribute its WavSTAT Optical Biopsy System for the support of colorectal cancer screening and diagnosis. The agreement, which includes the company’s new WavSTAT4 console and the disposable optical biopsy forceps, covers Europe as well as Turkey, Saudi Arabia and South Africa. PENTAX Medical is a leading provider of flexible endoscopes, which are used with the WavSTAT System during screening for colorectal cancer.

“We are looking forward to working with PENTAX Medical to bring this new technology to hospitals across Europe” said Michael Oliver, SpectraScience’s Chief Executive Officer. “PENTAX Medical is the ideal partner for our sales and marketing efforts in Europe. Their highly-regarded sales organization has the expertise to insure we get the maximum possible exposure in the gastroenterology community. With expanded distribution with PENTAX Medical, we create a situation where both companies have a vested interest in speeding the adoption of this unique technology across Europe.” Girts Cimermans, President Europe, Middle East and Africa, PENTAX Medical states: “We believe in an opportunity for this product and want to have a role in building its future. We are making efforts to pave the way for WavSTAT into clinical routine.”

About SpectraScience, Inc.

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate result. With the CE certification obtained, allowing the sales and shipments in the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.

About PENTAX Medical
…read more

Source: FULL ARTICLE at DailyFinance

MicroVision Secures Agreement with Leading Global Electronics Brand

By Business Wirevia The Motley Fool

Filed under:

MicroVision Secures Agreement with Leading Global Electronics Brand

MicroVision helps OEMs fuel the next generation of innovation in electronics

REDMOND, Wash.–(BUSINESS WIRE)– MicroVision (NAS: MVIS) , a leader in innovative ultra-miniature projection display technology, today announced a development agreement with a prominent electronics company to incorporate MicroVision’s ground breaking PicoP® display technology into a display engine that could enable a variety of new products.

Under the agreement MicroVision is supporting the OEM‘s development of a display engine based on patented PicoP display technology and includes $4.6 million in development fees to MicroVision over the next 13 months. The companies have begun commercial negotiations with the expectation that licensing and component supply agreements would constitute the next stage of engagement leading to the OEM‘s introduction of commercial products. At the request of MicroVision’s OEM customer, its name and other details of the contract are being kept confidential.

“We are pleased to sign this agreement and begin development with a Fortune Global 100 electronics giant,” said Alexander Tokman, president and CEO of MicroVision. “The execution of this latest agreement further solidifies our strategy to leverage our core expertise and that of our OEM partners to capture substantial new opportunities for PicoP display technology in our target markets. We believe this agreement, a milestone advancement of our “Image by PicoP®” licensing business model, helps build our pipeline for potential significant future revenue.”

The company’s “Image by PicoP®” licensing business model allows OEMs to create differentiation in their products by integrating MicroVision’s proprietary, advanced display technology. PicoP display technology is a powerful, patented solution that projects high definition, focus free content from a tiny, low power display engine. MicroVision’s technology enables OEMs to deliver a high quality consumer viewing experience to their customers by offering new and enhanced ways to view and share information. Whether for personal entertainment, social engagement, business collaboration, driver safety or in whatever way OEMs’ imaginations take them, PicoP display technology can be the new and exciting element that consumers are searching for to elevate their mobile content viewing experience.

Fueling the next generation of innovation is at the core of MicroVision’s business objectives. Helping to propel the success of MicroVision’s business model is the continued growth and demand for mobile connected devices. According to Steve Koenig, director of industry analysis for the Consumer Electronics Association (CEA), revenues for the consumer electronics (CE) industry are projected to reach a …read more
Source: FULL ARTICLE at DailyFinance

Alaska Communications Brings Carrier Ethernet 2.0 to Alaska and U.S.

By Business Wirevia The Motley Fool

Filed under:

Alaska Communications Brings Carrier Ethernet 2.0 to Alaska and U.S.

Advanced Ethernet Services Benefit Alaska Businesses

ANCHORAGE, Alaska–(BUSINESS WIRE)– Alaska Communications (NAS: ALSK) Alaska’s leading broadband solutions provider, today became the first company in Alaska and second in the U.S. to offer certified Carrier Ethernet 2.0 (CE 2.0) services.

The Metro Ethernet Forum (MEF), a global industry alliance that defines Carrier-class Ethernet networks and services, recognized Alaska Communications as a CE 2.0 service provider following its achievement of CE 2.0 certification. Alaska Communications is the third provider in the world to achieve CE 2.0 certification.

The certification means the company meets international standards for its business Ethernet services, making Alaska one of the best-connected business communities in the United States.

“The achievement of the CE 2.0 service providers is a testament to their commitment to outstanding delivery to the enterprise market. MEF CE 2.0 standards will enable enterprises to choose service providers with greater speed, clarity and certainty,” said Nan Chen, MEF president.

CE 2.0 services offer major industries in Alaska like oil & gas, finance, resource development, healthcare, education and government the dedicated, reliable, secure networks needed to operate at peak performance.

“Our business customers have critical needs and require reliable, modern Ethernet services. We are excited to offer that with Carrier Ethernet 2.0, demonstrating our commitment and leadership in bringing world-class networking capabilities to Alaska,” said Mike Todd, Alaska Communications senior vice president, customer operations.

CE 2.0 extends Carrier Ethernet with added features essential for carriers including multiple classes of service, greater manageability, easier interconnect for eight standard service types and greater mobile backhaul efficiency.

About Alaska Communications

Headquartered in Anchorage, Alaska Communications (NAS: ALSK) is a leading provider of high-speed wireless, mobile broadband, Internet, local, long-distance and advanced broadband solutions for businesses and consumers in Alaska. The Alaska Communications network includes advanced broadband and voice networks and the most diverse undersea fiber optic system connecting Alaska to the contiguous United States. For more information, please visit www.alaskacommunications.com or www.alsk.com.

About The Metro Ethernet Forum

…read more
Source: FULL ARTICLE at DailyFinance

ETView Medical, Ltd. Announces State Food and Drug Administration (SFDA, China) Clearance of a Pre-m

By Business Wirevia The Motley Fool

Filed under:

ETView Medical, Ltd. Announces State Food and Drug Administration (SFDA, China) Clearance of a Pre-marketing Notification Application for the VivaSight-SL Line of Innovative Airway Devices

TEL AVIV, Israel–(BUSINESS WIRE)– ETView (TASE: ETVW) today announced that the company has received clearance of a Pre-Marketing Notification Application with the State Food and Drug Administration (SFDA, China). The Company expects to enter the Chinese market with the VivaSight-SL immediately. VivaSight-SL will be exclusively distributed throughout China by the China National Pharmaceutical Group Corporation, SINOPHARM. Additional pre-market regulatory clearances world-wide are anticipated during 2013.

About the VivaSight-SL

VivaSight™-SL is a single-use disposable single lumen ventilation tube with an integrated continuous high resolution video imaging system for use in lung isolation procedures. VivaSight™-SL has been cleared for commercial distribution by the US FDA and has received CE pre-market clearance. Lung isolation is employed to provide one-lung ventilation in patients undergoing thoracic, cardiac, vascular or esophageal surgeries.1 It is estimated that over 1.9 million lung isolation procedures are conducted world-wide annually2, accounting for over $250MM in single-use medical disposables3.

“We are excited to have reached this milestone,” stated Bill Edelman, CEO. He continued, “VivaSight-SL is now available to the Chinese thoracic surgical community following SFDA clearance of our pre-market application. We anticipate significant clinical interest for this innovative technology in the markets where VivaSight-SL is cleared for commercial distribution. With our line of VivaSight™ products available in the US, South America, Europe and now China, ETView offers a complete airway management solution for 100% of lung-isolation surgeries. We look forward to additional regulatory clearances world-wide which will expand the market for our VivaSight™ portfolio.”

See www.etview.com for addition press announcements.

About ETView

ETView Medical Ltd. (TASE: ETVW) has successfully combined airway management with continuous direct airway visualization for medical professionals. ETView’s patented VivaSight™ airway management portfolio consists of single-use disposable medical devices, representing either single or double lumen ventilation tubes with an integrated continuous high resolution airway imaging system. VivaSight™-SL and VivaSight™-DL are currently sold in Europe, Israel, and the US to overcome current limitations and associated adverse surgical events during lung isolation surgeries.4

About SINOPHARM

China National Pharmaceutical Group Corporation, SINOPHARM, is the largest pharmaceutical and healthcare group under State-Owned Assets Supervision and Administration Commission of the State Council (SASAC) in China. The group has 22 wholly-owned subsidiaries and holding companies, one H-share listed company, Sinopharm Group Co., Ltd., and three A-share listed companies, Beijing Tiantan Biological Products Corporation Limited (BTBP), …read more
Source: FULL ARTICLE at DailyFinance

Signs Of Aging Include Contrasting Nature Of Facial Features

By The Huffington Post News Editors

When people look at someone, they unconsciously figure out how old that person is by studying the contrasting nature of his or her facial features. Or so says Psychology Professor Richard Russell, who has been collaborating with researchers from CE.R.I.E.S. (Epidermal and Sensory Research and Investigation Center), a department of Chanel Research and Technology dedicated to skin-related issues and facial appearance.

“Unlike with wrinkles, none of us are consciously aware that we’re using this cue, even though it stares us in the face every day,” said Russell in a press release.

He said the discovery of this tip-off to age perception may partly explain why people wear makeup in the way they do. For example, lipstick that makes the lips redder is actually making the face appear younger, he added.

Read More…
More on Chanel

…read more
Source: FULL ARTICLE at Huffington Post

Large solar proton event explains 774-775 CE carbon-14 increase

Tree ring records indicate that in 774-775 CE, atmospheric carbon-14 levels increased substantially. Researchers suggest that a solar proton event may have been the cause. In solar proton events, large numbers of high-energy protons are emitted from the Sun, along with other particles. If these particles reach Earth’s atmosphere, they ionize the atmosphere and induce nuclear reactions that produce higher levels of carbon-14; the particles also cause chemical reactions that result in depletion of ozone in the ozone layer, allowing harmful ultraviolet radiation to reach the ground. …read more
Source: FULL ARTICLE at Phys.org

BioLineRx Reports Year End 2012 Financial Results

By Business Wirevia The Motley Fool

Filed under:

BioLineRx Reports Year End 2012 Financial Results

JERUSALEM–(BUSINESS WIRE)– BioLineRx Ltd. (NAS: BLRX) (TASE: BLRX), a biopharmaceutical development company, today reported its results for the year ended December 31, 2012.

“BioLineRx is rapidly approaching a significant landmark in the evolution of the Company,” stated Kinneret Savitsky, Ph.D., CEO of BioLineRx. “We are eagerly anticipating the interim analysis of the on-going CLARITY Phase 2/3 trial for our lead compound, BL-1020 for schizophrenia, which we expect to receive next week. The analysis will include a recommendation by an independent Data Monitoring Committee (DMC) regarding the number of additional patients needed in order to reach statistical significance on the cognitive effect of BL-1020 compared to Risperidone. Although the data from the ongoing study is completely confidential, based on promising evidence received in previous clinical and pre-clinical trials, we hope the information received will provide a clear indication regarding the strength of the cognition improvement signal, thereby putting us in a stronger position to out-license BL-1020 and move towards commercializing the compound.”

“The PRESERVATION I pivotal CE mark registration trial for our other lead compound, BL-1040 for ventricular remodeling post-AMI, which is being carried out by Ikaria, Inc., continues to progress on an accelerated basis. Currently, there are 15 sites recruiting in Australia, Belgium, Canada, Israel and Spain, and results from the trial are expected in 2014.”

“In addition, our Phase 2 proof-of-concept study for BL-7040, an oral treatment for Inflammatory Bowel Disease (IBD), is nearing completion. This is an open-label study to evaluate the efficacy, pharmacodynamics, safety and tolerability of BL-7040 in up to 30 patients with moderately active ulcerative colitis, a type of IBD. This trial is being carried out at five sites in Israel, and we are expecting to announce results in April 2013.”

“During 2012, we in-licensed several high-profile therapeutic compounds that are already advancing towards clinical testing. This includes BL-8040, a Phase 2-ready drug for the treatment of acute myeloid leukemia (AML) and other hematological cancers. The interest in this program is high, and we have recently signed an agreement with one of the premier cancer centers in the world, MD Anderson Cancer Center in Houston, Texas, to be the lead site in the trial. We are currently in negotiations with two other U.S.-based, world-class facilities for their participation in the trial as well,” continued Dr. Savitsky.

“At the beginning of 2012, we entered the competitive HCV market with the in-licensing of two orally-available compounds for the treatment of Hepatitis C from world renowned experts …read more
Source: FULL ARTICLE at DailyFinance

Schwab and Texas Tech Celebrate Opening of Newly Remodeled Charles Schwab Personal Financial Plannin

By Business Wirevia The Motley Fool

Filed under:

Schwab and Texas Tech Celebrate Opening of Newly Remodeled Charles Schwab Personal Financial Planning Technology Complex

New Schwab Study Finds Next Generation Financial Professionals Drawn to Relationship Management Roles and Want to Create Careers on Their Own Terms

SAN FRANCISCO–(BUSINESS WIRE)– Charles Schwab and Texas Tech University celebrated the opening last week of thenewly renovated Charles Schwab Personal Financial Planning Technology Complex1 at a ribbon cutting event attended by university faculty, students and financial professionals currently studying at Texas Tech for CE credits. Over the past several years, Schwab has contributed millions of dollars in support to universities and has developed programs to help mentor, train and provide hands-on learning experiences for future financial services professionals.

Schwab’s Bernie Clark addresses the crowd at ribbon cutting event at Texas Tech. (Photo: Business Wire)

The Charles Schwab Personal Financial Planning Technology Complex at Texas Tech, originally constructed in 2009, is used today by more than 300 undergraduate and graduate students in the University’s Personal Financial Planning Department. It is an approximately 4,500 square foot facility that now includes two state-of-the art classrooms, a 16-unit technology lab, a high-tech conference room, and a recording room to produce high-quality distance education modules.

“Attracting young people to the RIA space is critical to the channel’s success going forward,” said Bernie Clark, head of Schwab Advisor Services. “We are honored to be working with Texas Tech and other universities to provide support for young people entering the business so that they can be strong champions for the independent advice model in the decades to come.”

In early February, Schwab conducted a study with students at Texas Tech to gain their perspective on the financial services industry.

Schwab Study Findings: Attracting and Retaining the Next Generation

Today’s developing financial advisors are gravitating to a career where they can interact daily with people and have a role in relationship management (69%), as well as do work that matters and help others achieve their goals (63%), according to a recent survey conducted by Schwab Advisor Services among more than 100 students studying Personal Financial Planning at Texas Tech University.

Additional study findings include:

LTSI v3.4 Released

By Noriaki

Part of supporting the demand for Linux in consumer electronics is ensuring there is a common Linux base that is maintained and supported for the typical lifetime of a consumer device, usually two years, and that supports a large variety of consumer electronics products. The Linux kernel is released at such a rapid pace that until now, device makers were doing significant back-porting, bug testing and driver development on their own, which carried substantial cost in terms of time-to-market, as well as development and engineering effort to maintain those custom kernels.

The Linux Foundation’s Consumer Electronics (CE) workgroup founded the Long Term Support Initiative (LTSI) to address this issue collaboratively. Today, the project provides for both an annual release of a Linux kernel suitable for supporting the lifespan of consumer electronics products and regular updates of those releases for two years. Linux kernel maintainer Greg Kroah-Hartman oversees this maintenance and the LTSI kernel tree for this industry-wide project created and supported by Hitachi, LG Electronics, NEC, Panasonic, Qualcomm Atheros, Renesas Electronics Corporation, Samsung Electronics, Sony and Toshiba.

This week the CE working group is releasing the LTSI 3.4 kernel. It is based on the Linux 3.4.25 kernel release and includes a number of backported features from newer releases.

Highlights from today’s release include:

* The Contiguous Memory Allocator (CMA), which is extremely useful for embedded devices that have very limited hardware resources and will better handle the large memory requirements of multimedia applications. CMA originally was merged into the 3.4.0 kernel release, but its functionality was quite limited. Since then, the feature has been significantly improved in the kernel.org releases and those fixes have been added to the LTSI 3.4 kernel release. For more information about this kernel option, please visit LWN.net.

* AF_BUS, a kernel-based implementation of the D-Bus protocol. This feature was created for systems that required a faster D-Bus speed than the existing userspace method could provide, specifically the automotive entertainment systems. For more information about this feature, please see LWN.net.

* CoDel (controlled delay), a transmission algorithm that optimizes TCP/IP network buffer control, is backported for LTSI 3.4. This is a feature used to help control the “buffer bloat” problem that has been identified by the networking community as an issue that all devices need to be aware of. This feature was backported from the 3.5.0 kernel.org release. For more information about it, please see this LWN.net post.

Platform specific board support was backported from newer kernel versions, allowing the Armadillo 800, AT91, kzm9d, kzm9g, and Marzen platforms to work properly with this release.

For more information about LTSI and the latest release, please visit the LTSI website.

Source: FULL ARTICLE at Linux Foundation

Agent Installation Issue on Ops Center

By Junaid Subhani

Hi guys . While installing the agent on an asset Solaris system:


root@system: /var/tmp/OC $ /opt/SUNWxvmoc/bin/agentadm configure -u root -p /var/tmp/OC/mypasswd -x 172.21.16.65
agentadm: Version 12.1.2.2161 launched with args: configure -u root -p /var/tmp/OC/mypasswd -x 172.21.16.65
Validating step : workarounds configure -u root -p /var/tmp/OC/mypasswd -x 172.21.16.65
Validating step : db configure -u root -p /var/tmp/OC/mypasswd -x 172.21.16.65
/var/run/cacao/instances/scn-agent/run/*.pid: No such file or directory
Validating step : sc_console configure -u root -p /var/tmp/OC/mypasswd -x 172.21.16.65
verified sc_console command is OK
Validating step : setup_hmp configure -u root -p /var/tmp/OC/mypasswd
Validating step : scn_agent configure
scn_agent Common Agent Container environment is OK
Validating step : setup_net configure
skipping setup_net step for zone VC.
Validating step : uce_agent configure
Validating step : config_sysconfig configure
Validating step : final configure
End of validation

executing step : workarounds
workaround configuration done.

executing step : db
/var/run/cacao/instances/scn-agent/run/*.pid: No such file or directory
configuring db
INFO: hd_domain_vc_agent_db.sh decrypted the password.
Java DB creation and initialization for Domain Model successful
configuring jobs db
INFO: hd_jobs_vc_agent_db.sh decrypted the password.
Java DB creation and initialization for job manager successful
INFO: db decrypted the password.

executing step : sc_console
verified sc_console command is OK
Configuring sc_console
*checking existing sc_console connections
doing sc-console registration
Jan 22, 2013 12:29:32 AM org.apache.commons.httpclient.HttpMethodDirector executeWithRetry
INFO: I/O exception (java.net.ConnectException) caught when processing request: Connection timed out
Jan 22, 2013 12:29:32 AM org.apache.commons.httpclient.HttpMethodDirector executeWithRetry
INFO: Retrying request
Jan 22, 2013 12:32:43 AM org.apache.commons.httpclient.HttpMethodDirector executeWithRetry
INFO: I/O exception (java.net.ConnectException) caught when processing request: Connection timed out
Jan 22, 2013 12:32:43 AM org.apache.commons.httpclient.HttpMethodDirector executeWithRetry
INFO: Retrying request
Jan 22, 2013 12:35:54 AM org.apache.commons.httpclient.HttpMethodDirector executeWithRetry
INFO: I/O exception (java.net.ConnectException) caught when processing request: Connection timed out
Jan 22, 2013 12:35:54 AM org.apache.commons.httpclient.HttpMethodDirector executeWithRetry
INFO: Retrying request
CE: java.net.ConnectException: Connection timed out
10
ERROR: Connection refused.
sc-console registration failed on [10].
sc-console : Unknown error. *


It does not seem to be connecting . What seems to be the issue here and how can I resolve it ?

Source: FULL ARTICLE at The UNIX and Linux Forums

CES Is Hot But CE Retail Sales Is Not

By Laura Heller, Contributor Technology, gadgets and games are among the few consumer products that consistently stir the imagination and get people talking. International CES commenced this week and mobile enhancements, home automation and super high def TVs are on display. But while CES is hot, retail sales are decidedly not. CE sales fell nearly […]
Source: FULL ARTICLE at Forbes Latest